EIT Digital Innovation Activity 'ki elements' Showcases its First Prototype: DELTA

EIT DigitalThe EIT Digital Innovation Activity 'ki elements' showcases its first prototype called DELTA in Nice at the Institut Claude Pompidou on Innovation Alzheimer Open Day.

In the beginning of 2017, EIT Digital launched ELEMENT, a new Innovation Activity to facilitate faster, earlier diagnosis and intervention for cognitive decline.

In June 2017, the Innovation Activity ELEMENT took a new step forward with the official launch of its start-up: ki elements.

CEO Jan Alexandersson (also Activity Lead) of ELEMENT explains: "We are very proud and happy to showcase our first prototype called Delta during the Innovation Alzheimer Day in collaboration with Association Innovation Alzheimer at the Institut Claude Pompidou in Nice. Our prototype is an iPad app for psychometric testing based on language as diagnosis support for professionals working in psychiatry, neuropsychology and speech pathology."

How the Delta app works:

  • Delta records and saves speech data and synchronises it with your HIS (Hospital Information System). This allows you to easily re-listen to patients and empowers your professional decisions.
  • Delta automatically transcribes answers from cognitive speech tests to keep your attention free for the most important thing: your work with the patient.
  • Delta leverages AI and computational linguistics to extract and analyse powerful scientific metrics from patients' answers.
  • Delta gives you comprehensive insight by visualising the extracted metrics. Combined with population cut-off values, this visualisation helps to enrich your professional impression
  • Delta compiles your test analysis, visualisations and your interpretation/diagnosis into a digital report formatted to your clinic's guidelines.

Jan Alexandersson continues: "We are hoping this prototype demo will help us find our potential first customers, collect feedback about our value proposition. We are also working on CE certification of our product and looking to extending our portfolio towards the German market by the end of 2018. For 2017, our focus is on the French market."

The mission of ki elements is to provide health professionals with AI-empowered tools as key elements to excel in their profession.

ELEMENT has implemented a first alpha version of the product targeting dementia diagnosis support for clinicians based on speech analysis.

Dementia is a cognitive disorder, mainly caused by neurodegenerative diseases, such as Alzheimer's disease but also strokes, which leads to a loss of autonomy and is associated with significant decrease in quality of life. In 2015 around the world, there were 9.9 million new cases of dementia: one every 3 seconds*. This number is expected to double every 20 years and reach 68% of the worldwide population in 2050 (mostly in low-medium income countries and due, in part, to fewer births and a growing elderly population).

Partners involved in the Innovation Activity are:

  • DFKI: Activity lead, coordination, mobile and app integration
  • ki elements (sub-grantee of DFKI GmbH): commercialisation of project results
  • Inria: Corpus collection, video analysis and clinical trials
  • University of Edinburgh: Trials and validation of current system for British English
  • Innovation Alzheimer (sub-grantee of INRIA): Clinical partner providing access to dementia patients for French corpus collection and tests. Clinical personnel will be involved.

    * Alzheimer's Disease International

    About EIT Digital
    EIT Digital seeks to generate significant innovations from top European research. As such, we focus our investments on a limited number of innovation areas known as Innovation Action Lines, that we have selected with respect to their European relevance and leadership potential. Each Innovation Action Line comprises a portfolio of activities including:

    • open innovation activities carried out by the EIT Digital Partners and
    • fast-growing technology startups that are ready to scale commercially.

    Our Innovation Activities deliver new products or services, create startups and spinoffs to commercialise outputs from projects and encourage the transfer of technologies for market entry.

  • Most Popular Now

    European Artificial Intelligence Act Com…

    The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

    Patient Safety must be Central to the De…

    An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

    ChatGPT Shows Promise in Answering Patie…

    The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

    Survey: Most Americans Comfortable with …

    Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

    AI Spots Cancer and Viral Infections at …

    Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

    Video Gaming Improves Mental Well-Being

    A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

    New Diabetes Research Links Blood Glucos…

    As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

    Machine learning helps identify rheumato…

    A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

    New AI Software could Make Diagnosing De…

    Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

    A New AI Tool for Cancer

    Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

    Vision-Based ChatGPT Shows Deficits Inte…

    Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

    Bayer Launches New Healthy-Aging Ecosyst…

    Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...